# X-Cor Therapeutics Inc. — Form D

X-Cor Therapeutics Inc. of ALSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-21. The offering totals $2.0M, of which $200K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2019-02-21
- Form: D
- Accession: 0001567619-19-005074
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $200K
- Remaining: $1.8M
- Investors: 3
- Date of first sale: 2019-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-333279

## Issuer

- Name: X-Cor Therapeutics Inc.
- CIK: 0001768464
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 127 WESTERN AVENUE, ALSTON, MA, 02134
- Phone: 301-801-0696

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Brian Chang | Director | New York, NY |
| Steven Keller | Director | Alston, MA |
| Jayon Wang | Director | Alston, MA |
| Jayon Wang | Executive Officer | Alston, MA |
| Jayon Wang | Promoter | Alston, MA |

## More

- [CIK 1768464 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1768464&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-19-005074.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.